ONEMEDNET CORPORATION Other General Expense
ONEMEDNET CORPORATION (ONMD) reported Other General Expense of $226.26 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherGeneralExpense · last filed 2024-04-09
- ONEMEDNET CORPORATION other general expense for the quarter ending 2023-12-31 was $63.80K, a 67.32% decline year-over-year.
- ONEMEDNET CORPORATION other general expense for the quarter ending 2022-12-31 was $195.23K.
- ONEMEDNET CORPORATION other general expense for fiscal 2023 was $226.26K, a 43.26% decline from fiscal 2022.
- ONEMEDNET CORPORATION other general expense for fiscal 2022 was $398.76K.
| Period end | Other General Expense 3 month | Other General Expense 9 month | Other General Expense 12 month |
|---|---|---|---|
| 2023-12-31 | $63.80K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-09 | $226.26K 10-K · filed 2024-04-09 | |
| 2023-09-30 | $162.45K 10-Q · filed 2023-11-20 | ||
| 2022-12-31 | $195.23K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-09 | $398.76K 10-K · filed 2024-04-09 | |
| 2022-09-30 | $203.53K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |